BML-278
(Synonyms:DIETHYL 1-BENZYL-4-PHENYL-1,4-DIHYDROPYRIDINE-3,5-DICARBOXYLATE锛圵S201542锛,WUXI APPTEC")
目录号 : KCM10626
CAS No. : 120533-76-8
纯度 : ≥95%
BML-278 is an activator of sirtuin 1 (SIRT1) that has an EC value (effective concentration able to increase the enzyme by 150%) of 1 µM. It less potently activates SIRT2 and SIRT3 (ECs = 25 and 50 µM, respectively). BML-278 induces hypoacetylation on α-tubulin in U937 cells that are pretreated with SAHA , a histone deacetylase inhibitor. It arrests cell cycling at the G/S phase, reduces senescence in primary human mesenchymal cells, and significantly increases mitochondrial density in murine C2C12 myoblasts.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 分子式 |
C24H25NO4
|
| 分子量 |
391.5
|
| CAS号 |
120533-76-8
|
| 中文名称 |
diethyl 1-benzyl-1,4-dihydro-4-phenylpyridine-3,5-dicarboxylate
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|